top of page


Defending Innovation: Why the 2025 Special 301 Report Must Take a Stand
Incubate has urged Congress to take action and ensure the 2025 Special 301 Report reaffirms America’s commitment to safeguarding...
Incubate Coalition
Feb 19, 2025


Incubate Responds to Next 15 Drugs Selected for Medicare Price Controls
WASHINGTON (January 17) -- Today, the Centers for Medicare & Medicaid Services announced the second round of Medicare Part D drugs...
Incubate Coalition
Jan 17, 2025


Incubate Survey Finds That Drug Price Controls Create Headwinds for Life Sciences Startups
WASHINGTON ( January 13 ) -- Today, Incubate Policy Lab released insights from a survey of life sciences venture capital investors about...
Incubate Coalition
Jan 12, 2025


Incubate 2024 Year in Review
2024 was Incubate's busiest year yet! From California to Japan, we traveled far and wide to educate policymakers and patient advocates on...
Incubate Coalition
Dec 13, 2024
bottom of page




